Brevan Howard Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-19,928
| Closed | -$575K | – | 996 |
|
|
2024
Q3 | $575K | Buy |
+19,928
| New | +$575K | ﹤0.01% | 592 |
|
|
2024
Q2 | – | Sell |
-10,415
| Closed | -$612K | – | 1002 |
|
|
2024
Q1 | $612K | Buy |
10,415
+6,072
| +140% | +$357K | 0.01% | 348 |
|
|
2023
Q4 | $260K | Buy |
+4,343
| New | +$260K | ﹤0.01% | 737 |
|
|
2023
Q3 | – | Sell |
-2,276
| Closed | -$207K | – | 334 |
|
|
2023
Q2 | $207K | Buy |
+2,276
| New | +$207K | ﹤0.01% | 146 |
|